Project Grant HT94252410825
Award Date
8/15/24
Completion Date
8/14/26
Dollars Obligated
$416K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
The Defense Health Agency awarded a $464,261 project grant to The Royal Institution For The Advancement Of Learning, a private, non-profit educational institution in Montreal, Canada, to develop the next generation of prognostic tools for localized clear cell renal cell carcinoma. The grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, will fund research to integrate genomic, clinical, and pathological features to create advanced prognostic tools for this...
This $769,073 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to define and target cancer cell-intrinsic vulnerabilities in renal cell carcinoma. The grant was awarded to the Royal Institution for the Advancement of Learning / McGill Office of Sponsored Research Division, a private university affiliated with McGill University in Montreal, Canada. The research will be conducted from August 1, 2024...
The Department of the Army Medical Command awarded a $1,339,689 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Feinstein Institutes for Medical Research. The purpose of this 4-year award, effective August 1, 2024, is to identify and functionally characterize metastasis-driving tumor cell subpopulations in localized stage III clear cell renal cell carcinoma. This research aims to transform healthcare for military service members and the broader...
The Department of the Army Medical Command awarded a $116,692 Project Grant to the Royal Institution For The Advancement Of Learning / McGill under the Military Medical Research and Development program. The grant will fund a research project titled "UNDERSTANDING PHYSICAL DETERMINANTS OF HETEROGENEITY IN RENAL CANCER CARCINOMA" from July 15, 2021 to July 14, 2023. The project will be performed at 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada. Through this funding, the awardee will...
The federal Project Grant award of $1,356,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) aims to support the "Restoration of Clear Cell Renal Cell Carcinoma Tumorigenicity by Cell Reprogramming" research at Weill Medical College of Cornell University. The award, which runs from November 1, 2024 to October 31, 2028, will fund advanced biomedical research focused on transforming healthcare for military service members and the...
The Defense Health Agency awarded a $5,099,737 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to 149 Bio LLC, located in Miami, Florida. The grant supports the development of a novel myeloid-targeted therapeutic for treating glomerular diseases. The four-year project, which commenced on July 1, 2025 and is scheduled for completion on June 30, 2029, aims to advance research and transformative healthcare solutions for military service members and the...
This federal Project Grant award of $110,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by University College Dublin (UCD) to investigate the role of the unfolded protein response in clear cell renal cell carcinoma, with the goal of developing novel therapeutic strategies for this disease. The project will be conducted over a one-year period from September 1, 2024 to August 31, 2025. The Military Medical...
This $524,340 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding the development of a rapid drug discovery pipeline for pediatric acute myelogenous leukemia using machine learning and in vitro feedback loops. The Research Institute of the McGill University Health Centre, a non-profit organization, is conducting this research over a 2-year period from Aug 2023 to Aug 2025. The grant supports transforming healthcare...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...